Leptin deficiency and leptin gene mutations in obese children from Pakistan

Warda Fatima1, Adeela Shahid, Muhammad Imran

  • 1Department of Human Genetics and Molecular Biology, University of Health Sciences, Lahore, Pakistan.

Insights

Congenital leptin deficiency, a rare genetic disorder causing obesity, was found in 9 out of 25 obese Pakistani children. Researchers identified novel and known leptin gene mutations in these patients.

Area of Science:

  • Genetics
  • Endocrinology
  • Pediatrics

Background:

  • Congenital leptin deficiency is a rare genetic disorder.
  • Characterized by hyperphagia and rapid weight gain in infancy.
  • Only 14 cases and 4 mutations reported globally.

Purpose of the Study:

  • Measure serum leptin levels in obese children.
  • Identify leptin gene mutations in deficient individuals.

Main Methods:

  • Recruited 25 obese children.
  • Measured serum leptin levels.
  • Performed leptin gene sequencing.

Main Results:

  • Leptin deficiency identified in 9 children (36%).
  • Homozygous mutations found in all deficient children.
  • Two novel mutations (c.481_482delCT, c.104_106delTCA) and one previously reported mutation (c.398delG) identified.

Conclusions:

  • Leptin deficiency may be common in obese Pakistani children.
  • Further research needed to confirm prevalence.
  • Highlights the role of leptin in childhood obesity.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...